Our Company
Welcome to HemaCare Corporation – a leading global provider of biological blood products and services since 1978.
HemaCare Corporation is a blood services company serving healthcare providers and the scientific community for over 30 years. HemaCare and its subsidiary, Coral Blood Services, perform therapeutic apheresis services, provide human-derived biological products, and support the implementation of cellular therapy based trials with apheresis collections.
Cellular Therapy
With our specialty being apheresis collection, we provide responsive and cost-effective services to organizations requiring GMP/GTP (Good Manufacturing Practices/Good Tissue Practices) compliant cell therapy manufacturing and testing with a fully integrated support infrastructure capable of initiating and managing preclinical research, Phase I through Phase III clinical trials, and commercial cell therapy applications. Learn more
Research Products
We specialize in the customization of human-derived biological products and services for organizations' research protocols. HemaCare's network of FDA registered collection centers ensures an inventory of customized biological blood products from donor subjects for their research activities.
Learn more
Therapeutic Apheresis
We provide therapeutic apheresis (TA) services at the patient's bedside or in an outpatient setting.
Learn more
Consulting Services
With over thirty years experience in blood banking and apheresis collections, we are an industry leading provider of human-derived biological products and services. We provide a wide range of consulting services in, but not limited to, SOP development, personnel training, and quality and regulatory compliance.
